• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
New study shows COVID-19 boosters strengthen protection in MS, even with immune-suppressing treatments 26 August 2025
MS News MS Trials
New study shows COVID-19 boosters strengthen protection in MS, even with immune-suppressing treatments
MSReactor: measuring thinking and memory over time 26 August 2025
MS News
MSReactor: measuring thinking and memory over time
Injectable form of Ocrevus® for relapsing remitting MS recommended for PBS listing 22 August 2025
MS News
Injectable form of Ocrevus® for relapsing remitting MS recommended for PBS listing
MS Australia cautiously welcomes new NDIS announcement 22 August 2025
MS News
MS Australia cautiously welcomes new NDIS announcement
MS Australia invests in groundbreaking projects 30 July 2025
MS News
MS Australia invests in groundbreaking projects
Making Aged Care work for Older People with Disability 29 July 2025
MS News
Making Aged Care work for Older People with Disability
From our CEO 29 July 2025
MS News
From our CEO
Early identification of MS risk using EBV antibodies 29 July 2025
MS Brainbank MS News MS Trials
Early identification of MS risk using EBV antibodies
New treatment for relapsing remitting MS recommended for PBS listing 26 June 2025
MS News
New treatment for relapsing remitting MS recommended for PBS listing
From our CEO 24 June 2025
MS News
From our CEO
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Instagram Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

New study shows COVID-19 boosters strengthen protection in MS, even with immune-suppressing treatments